Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Osiris Therapeutics Inc Announces Leadership Transition


Monday, 2 Dec 2013 04:30pm EST 

Osiris Therapeutics Inc:Says C. Randal Mills, PhD. will be stepping down as President and Chief Executive Officer of the company for personal reasons.Says Osiris` Chief Operating Officer, Lode Debrabandere, Ph.D., will assume the role of President and Chief Executive Officer pending Board confirmation. 

Company Quote

14.94
0.07 +0.47%
26 Dec 2014